期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

固定野调强放疗对局部晚期肺癌放射性肺炎的影响 被引量：2

原文传递
导出
摘要 放射性肺炎（RP）是胸部放射治疗最主要的剂量限制性不良反应。三维适形放疗（3D—CRT）能够使靶区剂量分布与靶区形状保持一致，靶区周围危及器官暴露体积减少，有可能使患者生存获益。固定野调强放疗（IMRT）较3D-CRT进一步提高靶区的剂量学参数，满足靶区剂量分布的需要，更好地避免对危及器官的照射。
作者 石健 王强 王冬青 刘洪付
机构地区 滨州医学院附属临淄区人民医院肿瘤放疗科 山东省肿瘤医院放疗科 滨州医学院
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2012年第6期633-634,共2页 Chinese Journal of Radiological Medicine and Protection
关键词 放射性肺炎 调强放疗 局部晚期肺癌 靶区剂量 胸部放射治疗 剂量分布 三维适形放疗 3D-CRT
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1曹建忠,欧广飞,梁军,吕纪马,周宗玫,陈东福,肖泽芬,冯勤付,张红星,王绿化,殷蔚伯.三维适形放疗治疗局部晚期非小细胞肺癌的疗效[J].中华肿瘤杂志,2011,33(7):529-534. 被引量：35
  • 2Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell tung cancer. Int J Radiat Oncol Biol Phys ,2004,58 (4) : 1258-1267.
  • 3Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2004, 58(4) :1268-1279.
  • 4Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Onco1,2004,71 (2) : 175-181.
  • 5Yom SS, Liao Z, Liu HH, et al. Initial evaluation of treatment- related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity- modulated radiotherapy. Int J Radiat Oncol Biol Phys,2007,68 ( 1 ) : 94-102.
  • 6Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis(TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys, 2006,66 (5) : 1399-1407.
  • 7Dang J, Li G, Lu X, et al. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non- small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol, 2010, 136 (8): 1169-1178.
  • 8Moreno M, Aristu J, Ramos LI, et al radiatlon-induced pulmonary toxicity Predictive factors for after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer. Clin Transl Oncol, 2007, 9(9) :596-602.
  • 9Salama JK, Stinchcombe TE, Gu L, et al. Pulmonary toxicity in stage Ⅲ non-Small cell lung cancer patients treated with high- dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of cancer and leukemia group B (CALGB) trial 30105. Int J Radiat Oncol Biol Phys, 2011, 81 (4): e269-274.
  • 10Liao ZX, Komaki RR, Thames HD Jr, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys,2010,76(3) : 775-781.

二级参考文献11

  • 1梁军,冯勤付,张可,章众,吕纪马,欧广飞,王绿化.肺癌三维适形放疗与常规放疗剂量学优势的比较[J].临床肿瘤学杂志,2006,11(11):814-817. 被引量：30
  • 2欧广飞,王绿化,张红星,陈东福,肖泽芬,冯勤付,周宗玫,吕纪马,梁军,汪楣,殷蔚伯.289例局部晚期非小细胞肺癌放疗和放化综合治疗结果[J].中华放射肿瘤学杂志,2007,16(2):86-90. 被引量：30
  • 3Socinski MA, Zhang C, Hemdon JE 2nd, et al. Combined modality trials of the Cancer and Leukemia Group B in stage Ⅲ non-small- cell lung cancer: analysis of factors influencing survival and toxicity. Ann Oncol, 2004, 15:1033-1041.
  • 4Price KA, Azzoli CG, Gaspar LE. Chemoradiation for unresectable stage Ⅲ non-smaU cell lung cancer. Semin Thorac Cardiovase Surg, 2008, 20:204-209.
  • 5Wilsona EM, Joy Williams F, Lyn BE, et al. Comparison of two dimensional and three dimensional radiotherapy treatment planning in locally advanced non-small cell lung cancer treated with continuous hyperfractionated accelerated radiotherapy weekend less. Radiother Oncol, 2005, 74:307-314.
  • 6Fang LC, Komaki R, Allen P, et al. Comparison of outcomes for patients with medically inoperable stage Ⅰ non-small-cell lung treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys, 2006, 66:108-116.
  • 7Hansen O, Paarup H, Scrensen P, et al. Curative radiotherapy of local advanced non-small-cell lung cancer: eight years of experience from Odense. UgeskrLaeger, 2005, 167:3497-3502.
  • 8Rosenman JG, Halle JS, Socinski MA, et al. High-dose conformal radiotherapy for treatment of Stage Ⅲ A/Ill B non-small-cell lung cancer: technical issues and results of a phase Ⅰ / Ⅱ trial. Int J Radiat Oncol Biol Phys, 2002, 54:348-356.
  • 9Wang L, Correa CR, Zhao L, et al. The effect of radiation dose and chemotherapy on overall survival in 237 patients with stage Ⅲ non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2009, 73 : 1383-1390.
  • 10Rosell R. The integration of newer agents into neoadjuvant therapy. Semin Oncol, 1998, 25(3 Suppl 8) :24-27.

共引文献34

同被引文献12

  • 1贾丽,王仁本,于金明,孟繁会,郭英华,李金丽,朱昆莉.食管癌放疗后复发的再放疗32例疗效观察[J].中华肿瘤防治杂志,2006,13(11):863-864. 被引量：34
  • 2Song GH, Pyo H, Moon SH, et al. Treatment-related pneumonitis and acute esophagitis in non-small cell lung cancer patients treated with chemotherapy and helical tomotherapy[J]. Int J Radiat Oncol Biol Phys, 2010, 78(3): 651-658.
  • 3Jo I, Kay C, Kim J, et al. Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases[J]. J Radiat Res, 2014, 55(1): 105-112.
  • 4van der Geld YG, van Triest B, Verbakel WFAR, et al. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma[J]. Int J Radiat Oncol Biol Phys, 2008,72(4): 1215-1220.
  • 5Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans[J]. J Neurosurg, 2000, 93(Suppl 3): 219-222.
  • 6Yang J, Amini A, Williamson R, et al. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy[J]. Pract Radiat Oncol, 2013, 3(4): e139-e147.
  • 7Li HQ, Wang YJ, Li J, et al. The application of gamma stereotactic body radiation therapy in stage I/II non-small-cell lung cancer. Promising and encouraging outcome[J]. Saudi Med J, 2013, 34 (11): 1139-1144.
  • 8Kissick MW, Mo XH, McCall K, et al. A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management[J]. Phys Med Biol, 2010, 55 (10): 2983-2995.
  • 9Kissick MW, Flynn RT, Westerly DC, et al. On the impact of longitudinal breathing motion randomness for tomotherapy delivery[J]. Phys Med Biol, 2008, 53 (18): 4855-4873.
  • 10Qiu J, Liu ZK, Yang B, et al. Low-dose-area-constrained helical tomotherapy-based whole breast radiotherapy and dosimetric comparison with tangential field-in-field IMRT[J]. Biomed Res Int, 2013,2013: 513708.

引证文献2

二级引证文献3

中华放射医学与防护杂志
2012年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部